)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Medicure
Medicure (MPH) investor relations material
Medicure Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor presentation summary4 May, 2026
Strategic focus and growth initiatives
Emphasis on expanding sales of ZYPITAMAG, AGGRASTAT, and Marley Drug pharmacy subsidiary.
Completion of Phase 3 trial for MC-1 targeting rare pediatric disease to obtain a priority review voucher.
Initiation of pre-clinical development for new chemical entities based on pyridoxal 5'-phosphate analogues.
Growth strategy includes reinvesting profits into R&D and acquisitions, with a focus on building the pharmacy business and developing new drugs for unmet needs.
Recent acquisitions of Gateway Medical Pharmacy and West Olympia Pharmacy to enhance distribution and marketing efficiency.
Financial performance and key metrics
Net revenue projected to grow from 2023 to 2025, with contributions from AGGRASTAT, ZYPITAMAG, and pharmacy business.
R&D expenses remain steady, with a notable cash outflow in 2025 due to pharmacy acquisitions.
EBITDA and net loss figures indicate ongoing investment in growth, with negative net cash change in 2025.
Product highlights and market positioning
ZYPITAMAG achieved $6.5M in 2025 sales, up 5% year-over-year, targeting the $4B statin market.
Marley Drug pharmacy generated $20.3M in 2025, up 188% from the prior year, expanding direct-to-consumer reach.
AGGRASTAT sales declined 29% to $5.7M in 2025, but remains a leading IV antiplatelet used in over 1,000 hospitals.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Medicure
- Revenue grew 32% to CAD 28.9M, but net loss widened to CAD 7.1M on CMS rebate and R&D.MPH
Q4 202528 Apr 2026 - Net income rose to $680K on $5.2M revenue, aided by a $1.9M legal settlement and pharmacy growth.MPHQ3 202420 Apr 2026
- Stable revenue, higher net loss, and growth in Marley Drug and ZYPITAMAG segments.MPHQ4 202420 Apr 2026
- Q2 2024 net loss of CAD 1.2 million amid revenue decline and higher R&D costs.MPHQ2 20241 Feb 2026
- Revenue up 29% to $6.7M, net loss narrows, and pharmacy acquisitions drive growth.MPHQ2 202523 Nov 2025
- Revenue rose to CAD 8.2M, but net loss widened to CAD 1.4M amid Aggrastat declines and higher costs.MPHQ3 202520 Nov 2025
- Net loss of CAD 694,000 on CAD 5.5 million revenue as AGGRASTAT sales fell amid competition.MPHQ1 202514 Nov 2025
Next Medicure earnings date
Q1 202621 May, 2026
Medicure
Next Medicure earnings date
Q1 202621 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage